Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ZGNX

Zogenix (ZGNX) Stock Price, News & Analysis

Zogenix logo

About Zogenix Stock (NASDAQ:ZGNX)

Advanced Chart

Key Stats

Today's Range
$26.68
$26.68
50-Day Range
$26.10
$26.68
52-Week Range
$11.03
$26.90
Volume
94 shs
Average Volume
3.76 million shs
Market Capitalization
$1.50 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ZGNX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zogenix and its competitors with MarketBeat's FREE daily newsletter.

ZGNX Stock News Headlines

Hwasung Industrial Co Ltd 002460
This Social Security Shift Could Boost Benefits by 400%
If you currently collect Social Security—or plan to in the future—this may be one of the most important updates you'll ever see. A new initiative, linked to President Trump's Executive Order #14196, has the potential to do more than just protect Social Security from collapse... According to renowned investor Louis Navellier, it could increase benefits by as much as 400%.
Alcon (NYSE: ALC)
Longeveron Inc Ordinary Shares - Class A
Biocryst Pharmaceuticals
See More Headlines

ZGNX Stock Analysis - Frequently Asked Questions

Zogenix, Inc. (NASDAQ:ZGNX) announced its quarterly earnings results on Thursday, November, 4th. The company reported ($1.04) earnings per share for the quarter, missing the consensus estimate of ($0.96) by $0.08. Zogenix's revenue for the quarter was up 690.6% compared to the same quarter last year.
Read the conference call transcript
.

Based on aggregate information from My MarketBeat watchlists, some other companies that Zogenix investors own include Bristol Myers Squibb (BMY), QUALCOMM (QCOM), Gilead Sciences (GILD), GW Pharmaceuticals (GWPH), Intel (INTC), Meta Platforms (META) and NVIDIA (NVDA).

Company Calendar

Last Earnings
11/04/2021
Today
8/02/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:ZGNX
CIK
1375151
Employees
218
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($4.07)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$209.38 million
Net Margins
-278.38%
Pretax Margin
-278.26%
Return on Equity
-91.20%
Return on Assets
-43.60%

Debt

Debt-to-Equity Ratio
0.88
Current Ratio
3.63
Quick Ratio
4.74

Sales & Book Value

Annual Sales
$81.69 million
Price / Sales
18.36
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$6.64 per share
Price / Book
4.02

Miscellaneous

Outstanding Shares
56,227,000
Free Float
53,922,000
Market Cap
$1.50 billion
Optionable
Optionable
Beta
0.89
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:ZGNX) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners